Breast-conserving surgery

SimBioSys® Appoints Renowned Surgical Oncologist, Dr. Barry Rosen, as Chief Medical Officer Following First FDA Clearance for TumorSight™ Precision Medicine Platform

Retrieved on:

星期五, 一月 12, 2024

This significant move coincides with the company's milestone achievement of receiving its first FDA clearance on its digital precision medicine platform, TumorSight™, and accelerating the development of additional offerings on the platform.

Key Points:

This significant move coincides with the company's milestone achievement of receiving its first FDA clearance on its digital precision medicine platform, TumorSight™, and accelerating the development of additional offerings on the platform.
His addition comes at a crucial juncture as we bring TumorSight™ to market, expand our clinical portfolio and advance our groundbreaking research product, PhenoScope™.
In a previous article interviewing Dr. Rosen, he shared his thoughts on the need and impact TumorSight™ could have, starting with TumorSight™ Plan.
That's what we're striving for with breast cancer surgery - we have that level of technology already for home projects, but we don't have it yet for this field."

Malaysia Healthcare Promotes Regular Screenings for Breast Cancer Prevention

Retrieved on:

星期二, 十月 31, 2023

KUALA LUMPUR, Malaysia, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Malaysia Healthcare encourages global citizens to practice regular examination and screenings as a crucial step in preventing breast cancer.

Key Points:

KUALA LUMPUR, Malaysia, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Malaysia Healthcare encourages global citizens to practice regular examination and screenings as a crucial step in preventing breast cancer.
With healthcare facilities that are equipped with innovative screening procedures, Malaysia Healthcare is committed to making breast cancer early detection accessible for global citizens.
In conjunction with the breast cancer awareness month, Malaysia Healthcare shed light on the significance of early diagnosis as well as the cutting-edge screening procedures provided by several of its healthcare facilities.
“We strongly advocate regular self-examination and frequent breast screening especially for women aged 40 and above to detect breast cancer at an early stage.

MHTC and Cancer Care Experts Join Forces, Fuelled by #Thrive365, to Shine a Light on Breast Cancer Awareness Month

Retrieved on:

星期六, 十月 14, 2023

Yee, Knowledge, Breast cancer, Heredity, Disease, Breast, Environment, Statistics, Breast-conserving surgery, History, Birth control

The event aimed to create more awareness on the importance of early detection and provide valuable insights into breast cancer prevention and screening methods.

Key Points:

The event aimed to create more awareness on the importance of early detection and provide valuable insights into breast cancer prevention and screening methods.
The panel discussion is aligned with this year's breast cancer awareness month theme, Thrive365.
Breast cancer affects both genders, and it is crucial to raise awareness about the disease among men as well.
Through initiatives like discussions, MHTC aims to empower individuals with knowledge and encourage proactive steps towards breast cancer prevention and early detection.

Dilon Technologies Selects AcuityMD Platform to Accelerate its Preventative Breast Cancer Surgery Devices to More Oncologists

Retrieved on:

星期二, 四月 4, 2023

AcuityMD , providers of a novel commercial platform for medical technology (MedTech) companies, has signed a multi-year contract with Dilon Technologies , a global leader in devices for breast cancer treatment and diagnosis.

Key Points:

AcuityMD , providers of a novel commercial platform for medical technology (MedTech) companies, has signed a multi-year contract with Dilon Technologies , a global leader in devices for breast cancer treatment and diagnosis.
In the first month alone, AcuityMD’s platform enabled Dilon to research over 1,700 new surgeons and their clinical practices to quickly determine if their patients may benefit from MarginProbe.
Dilon’s MarginProbe®, a groundbreaking technology for in-surgery, real-time breast cancer margin assessment, has shown a relative reduction of re-excision rates ranging from 25% up to 80%.
Re-excision after breast-conserving surgery (BCS) is common, with high rates of re-operation associated with adverse outcomes and unnecessary complications.

Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee

Retrieved on:

星期四, 十二月 16, 2021

Radiology, Biotechnology, Surgery, Oncology, Health, Medical Devices, Hospitals, Clinical Trials, Product, Forward-looking statement, Hope, OTC, Marie Cassidy, FDA, Principal investigator, Clinical trial, Physician, Algorithm, Intelligence, Medical imaging, ATLAS, Adult, Baylor College of Medicine, SEDAR, Public expenditure, Woman, Cancer Prevention and Research Institute of Texas, Breast cancer, Female, Breast Cancer Awareness Month, Time, Research institute, International Center for Ethnobotanical Education, Research and Service, AI, Cancer prevention, Perimeter, Risk, Baylor University, Research, TSX Venture Exchange, OCT, Patient, Artificial intelligence, Awareness, Radiology, Surgeon, MD, Legislation, Education, Breast-conserving surgery, Deep learning, Analysis, Tax, News, Technology, Medical device, West Cancer Center & Research Institute, the Clinical Development of Perimeter B-Series OCT with ImgAssist AI, Perimeter S-Series OCT, Perimeter Medical Imaging AI, Inc., WEST CANCER CENTER & RESEARCH INSTITUTE, THE CLINICAL DEVELOPMENT OF PERIMETER B-SERIES OCT WITH IMGASSIST AI, PERIMETER S-SERIES OCT, PERIMETER MEDICAL IMAGING AI, INC.

Dr. Richard E. Fine, Director of Education & Research, Margaret West Comprehensive Breast Center, West Cancer Center & Research Institute, stated, We are excited to be the first site to enroll a patient in the Perimeter pivotal trial that is evaluating the use of Perimeter B-Series OCT imaging technology combined with artificial intelligence.

Key Points:

Dr. Richard E. Fine, Director of Education & Research, Margaret West Comprehensive Breast Center, West Cancer Center & Research Institute, stated, We are excited to be the first site to enroll a patient in the Perimeter pivotal trial that is evaluating the use of Perimeter B-Series OCT imaging technology combined with artificial intelligence.
There is a strong unmet medical need to provide breast cancer surgeons with specimen imaging tools to aid their decisions real time in the operating room.
West Cancer Center & Research Institute is a leader in adult cancer care guided by physicians to provide the most positive outcomes though research, novel therapies, advanced treatments, and cancer prevention to all patients, regardless of socioeconomic status.
About Perimeter Medical Imaging AI, Inc.
With headquarters in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company that is driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need.

Overcoming Misconceptions and Worries About Post Mastectomy Breast Reconstruction

Retrieved on:

星期三, 六月 9, 2021

Breast surgery, Clinical medicine, Medicine, Medical specialties, Breast cancer, Breast reconstruction, Cancer, Breast-conserving surgery, Breast cancer awareness

Dr. Chen observes that "Many women feel that after completing treatment for breast cancer, breast reconstruction has a positive impact on their quality of life."

Key Points:

Dr. Chen observes that "Many women feel that after completing treatment for breast cancer, breast reconstruction has a positive impact on their quality of life."
And yet she adds that more education is needed around breast cancer and breast reconstruction.
Dr. Chen stressed the importance of overcoming common misconceptions
Five Top Misconceptions and Worries about Breast Reconstruction:
#1: Breast reconstruction is not possible after radiation or chemotherapy.
Radiation and chemotherapy may determine the timing and ideal type of breast reconstruction, but they do not rule out breast reconstruction altogether.

World-Renowned Pioneers in Oncoplastic Surgery Featured at Upcoming Global Summit in Las Vegas, January 2020

Retrieved on:

星期四, 十一月 7, 2019

Medicine, Breast surgery, Breast-conserving surgery, Plastic surgery, Surgery, Las Vegas

LAS VEGAS, Nov. 07, 2019 (GLOBE NEWSWIRE) -- The School of Oncoplastic Surgery (SOS) announced today that it will host its Global Summit in Las Vegas from January 24 to 26, 2020.

Key Points:

LAS VEGAS, Nov. 07, 2019 (GLOBE NEWSWIRE) -- The School of Oncoplastic Surgery (SOS) announced today that it will host its Global Summit in Las Vegas from January 24 to 26, 2020.
Oncoplastic surgery is the most advanced form of breast cancer surgery, combining traditional surgical techniques with plastic and reconstructive methods to achieve the best possible results.
The Global Summit, led by world-renowned pioneers in oncoplastic surgery, is widely considered the premier and most comprehensive program in the U.S.
Following the Global Summit in Las Vegas, SOS will host its first international meeting offshore on May 15 to 17, 2020 in Auckland, New Zealand.

US and European Interventional Oncology Devices Market Assessment for Breast Cancer During the Forecast Period, 2016-2020 - ResearchAndMarkets.com

Retrieved on:

星期二, 十月 8, 2019

Medical devices, Health, Medicine, Clinical medicine, Medical specialties, Breast surgery, Surgical oncology, Mastectomy, Breast cancer, Interventional oncology, Radical mastectomy, Breast-conserving surgery, Breast cancer management

The "US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020" report has been added to ResearchAndMarkets.com's offering.
The research service provides an overview of the interventional oncology devices market for breast cancer in the big five countries in Europe and in the United States.
Breast cancer surgical treatment has evolved from the days of the radical mastectomy to breast conservation surgery.
Market Overview of Interventional Oncology Devices for Breast Cancer, US and Europe
View source version on businesswire.com: https://www.businesswire.com/news/home/20191008005643/en/

Oncoplastic Surgery to be Focus of TME Foundation's Inaugural Course

Retrieved on:

星期二, 五月 21, 2019

Medicine, Medical specialties, Surgery, Breast surgery, Breast-conserving surgery, Cosmetic surgery, Surgical specialties, Otorhinolaryngology, Plastic surgery, The American Society of Breast Surgeons

Surgeons will gather in Chicago, June 28-29, 2019, to learn from some of the nation's leading experts in oncoplastic surgery (OPS).

Key Points:

Surgeons will gather in Chicago, June 28-29, 2019, to learn from some of the nation's leading experts in oncoplastic surgery (OPS).
OPS combines breast cancer surgery with plastic and reconstructive techniques to achieve the best possible cosmetic outcomes without compromising cancer care.
The goal of the course is to enable participants to offer oncoplastic surgery to all of their patients and to differentiate those that can be done alone versus a team-approach.
The course provides 16 CME credits, which attendees can apply toward the recently announced oncoplastic surgery certification from the American Society of Breast Surgeons (ASBrS).

Breast Reconstruction Specialist & Plastic Surgeon Dr. Constance M Chen Provides Tips for a Comfortable Recovery

Retrieved on:

星期二, 四月 30, 2019

Medicine, Breast surgery, Clinical medicine, Medical specialties, Breast reconstruction, Plastic surgery, Mastectomy, Surgery, Breast-conserving surgery, Preventive mastectomy

Clothes should be loose and comfortable and they should slip on easily and close in the front with zippers or buttons.

Key Points:

Clothes should be loose and comfortable and they should slip on easily and close in the front with zippers or buttons.
"After surgery, both physical and emotional factors determine how well and quickly a woman will heal," says plastic surgeon and breast reconstruction specialist Dr. Constance M. Chen .
"One or more surgical drains are usually required following mastectomy and reconstructive surgery," says Dr. Chen.
Constance M. Chen, MD , is a board-certified plastic surgeon with special expertise in the use of innovative natural techniques to optimize medical and cosmetic outcomes for women undergoing breast reconstruction.